Amphetamines vs placebo
ADHD symptom severity: clinician rated · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
3 findings from 1 review
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes onlyno estimate extracted1 study · 49 participantsVery low
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes onlyno estimate extracted7 studies · 896 participantsLow
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults 2018 · Cochrane Headline outcomes onlyno estimate extracted5 studies · 1083 participantsLow